Pulse wave velocity is more closely associated with cardiovascular risk than augmentation index in the relatively low-risk population.

Heart and Vessels
Bong Gun SongSeung Woo Park

Abstract

Pulse wave velocity (PWV) and augmentation index (AI) are both indirect indicators of arterial stiffness, which is an independent predictor of morbidity and mortality in cardiovascular diseases. The aim of this study was to assess the association between carotid AI (CAI), carotid-femoral PWV (CFPWV), and Framingham risk score (FRS), and to evaluate the factors determining CAI and CFPWV. Carotid AI and CFPWV were measured by applanation tonometry in 177 consecutive subjects without evidence of significant cardiovascular disease. Correlations between CAI and FRS and CFPWV and FRS were analyzed and major determinants of CAI and CFPWV were assessed. The mean age was 60.5 +/- 11.9 years and 112 (63%) of study patients were men. There was a significant association between CFPWV and FRS (r = 0.417, P < 0.001) and a weaker but also significant relation between CAI and FRS (r = 0.267, P < 0.001). CFPWV was significantly related to FRS in both men and women (P < 0.001 in both sexes), whereas the relation between CAI and FRS was significant only in women (P < 0.001). Our results suggest that CFPWV may be associated with CVD risk irrespective of sex, whereas CAI may be associated with CVD risk in women only.

References

Nov 7, 1992·Lancet·E D LehmannR G Gosling
Mar 1, 1992·Diabetic Medicine : a Journal of the British Diabetic Association·E D LehmannP H Sönksen
Aug 1, 1993·Journal of the American College of Cardiology·E D Frohlich
Aug 1, 1997·Journal of the American College of Cardiology·C RajkumarA M Dart
Apr 30, 1998·Journal of the American College of Cardiology·H SmulyanG M London
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Nov 29, 2001·Journal of Hypertension·C D GatzkaUNKNOWN ANBO2 investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-Based Tre
Nov 29, 2001·Journal of Hypertension·T K WaddellB A Kingwell
Mar 21, 2002·Clinical and Experimental Pharmacology & Physiology·B P McGrathJ D Cameron
Dec 11, 2002·Journal of Hypertension·Jens NürnbergerRafael F Schäfers
May 15, 2003·American Journal of Hypertension·Pierre LaurentMichel E Safar
Jun 14, 2003·The American Journal of Cardiology·Miriam Y Cortez-CooperHirofumi Tanaka
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·Anna A AhimastosBronwyn A Kingwell
Apr 6, 2004·American Journal of Hypertension·Charalambos VlachopoulosChristodoulos Stefanadis
Aug 4, 2004·American Journal of Hypertension·Daniel A DuprezJay N Cohn
Feb 3, 2005·American Journal of Hypertension·Wilmer W Nichols
Oct 1, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Seong-Mi ParkYoung-Moo Ro
Feb 8, 2006·Circulation·Francesco U S Mattace-RasoJacqueline C M Witteman
Nov 23, 2006·Age and Ageing·Francesco FantinChakravarthi Rajkumar
Jan 11, 2007·Journal of Hypertension·Masato SakuraiMasaaki Ito
May 29, 2007·American Journal of Hypertension·Mitul VyasGary F Mitchell
Jun 22, 2007·Clinical and Experimental Pharmacology & Physiology·Sophia Zoungas, Roland P Asmar
Jul 24, 2008·Heart and Vessels·Katarzyna Mizia-StecAdrianna Gościńska

❮ Previous
Next ❯

Citations

Nov 27, 2010·Heart and Vessels·Olga TrojnarskaLucyna Kramer
Dec 15, 2010·Heart and Vessels·Roberto NerlaFilippo Crea
Dec 25, 2010·Heart and Vessels·Andrea LászlóPéter Studinger
Dec 3, 2013·Canadian Journal of Physiology and Pharmacology·David H Kim, Branko Braam
Sep 5, 2014·Scandinavian Journal of Clinical and Laboratory Investigation·Siiri HjeltNina Hutri-Kähönen
May 24, 2012·Blood Pressure·Satoko MitaniYoshiyuki Watanabe
May 25, 2012·Annales de cardiologie et d'angéiologie·M HallabG Berrut
Jan 4, 2013·The Journal of Clinical Hypertension·Jason T DavisDaniel T O'Connor
Oct 16, 2012·Acta Paediatrica·Marco MeucciScott R Collier
Aug 29, 2013·Clinical & Developmental Immunology·Ping LiLi-Qi Bi
Apr 25, 2012·International Journal of Cardiology·Elisabeth LambertGavin Lambert
Feb 22, 2011·International Journal of Cardiology·Katarzyna Mizia-StecZbigniew Gąsior
Jun 17, 2014·Journal of Korean Medical Science·Shin Yi JangDuk-Kyung Kim
May 26, 2017·European Journal of Gastroenterology & Hepatology·Veeravich JaruvongvanichSikarin Upala
Aug 2, 2018·BMC Pregnancy and Childbirth·Paul M C LemmensJoyce H D M Westerink
Oct 30, 2020·Risk Management and Healthcare Policy·Zhi-Xin HuangZhenguo Liu
Jun 8, 2021·Metabolic Syndrome and Related Disorders·David KarasekLudek Slavik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.